Scroll Back to Top

Molecular Alterations in Non-Small Cell Lung Cancer

May 1, 2024

This review discusses the rationale behind molecular testing of patients with advanced NSCLC, highlights the benefits of comprehensive genomic profiling at diagnosis and presents four cases that demonstrate the need for tissue stewardship in the context of biomarker testing.

Read the white paper